ALPS Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $451K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $396K | Hold |
|
|||||
|
2024
Q3 | $334K | Buy |
|
|||||
|
2024
Q2 | $343K | Sell |
|
|||||
|
2024
Q1 | $346K | Sell |
|
|||||
|
2023
Q4 | $384K | Sell |
|
|||||
|
2023
Q3 | $347K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $310K | Sell |
|
|||||
|
2020
Q1 | $244K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $3.25M | Sell |
|
|||||
|
2016
Q4 | $3.23M | Sell |
|
|||||
|
2016
Q3 | $5.6M | Sell |
|
|||||
|
2016
Q2 | $5.53M | Buy |
|
|||||
|
2016
Q1 | $3.85M | Sell |
|
|||||
|
2015
Q4 | $6.42M | Sell |
|
|||||
|
2015
Q3 | $53.5K | Buy |
|
|||||
|
2015
Q2 | $4.05M | Buy |
|
|||||
|
2015
Q1 | $1.65M | Buy |
|